The JAK/STAT pathway involves JAK1/2 and STAT1-6, with JAK1/2-STAT3 receiving the most attention because of its core regulatory role in malignant tumor progression [6], such as in hepatocellular [7], colorectal [8], cervical [9] and bladder cancer [10]. This evidence concerns the gene JAK1 and urinary bladder carcinoma.